Literature DB >> 19036106

MIRN199B downregulation in chronic myeloid leukaemia is associated with deletions on der(9).

Francesco Albano, Luisa Anelli, Antonella Zagaria, Vincenzo Liso, Mariano Rocchi, Giorgina Specchia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19036106     DOI： 10.1111/j.1365-2141.2008.07459.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  5 in total

Review 1.  New insights in cellular and molecular aspects of BM niche in chronic myelogenous leukemia.

Authors:  Saeid Shahrabi; Shirin Azizidoost; Mohammad Shahjahani; Fakher Rahim; Ahmad Ahmadzadeh; Najmaldin Saki
Journal:  Tumour Biol       Date:  2014-09-19

2.  Molecular cytogenetic study of derivative chromosome 9 deletion in chronic myeloid leukemia patients.

Authors:  Ayda Bennour; Ines Ouahchi; Yosra Ben Youssef; Monia Zaier; Mohamed Adnéne Laatiri; Imed Harrabi; Balkis Meddeb; Moez Elloumi; Abderrahim Khelif; Ali Saad; Halima Sennana
Journal:  Med Oncol       Date:  2011-04-03       Impact factor: 3.064

Review 3.  Dysregulation of miRNA in Leukemia: Exploiting miRNA Expression Profiles as Biomarkers.

Authors:  Luisa Anelli; Antonella Zagaria; Giorgina Specchia; Pellegrino Musto; Francesco Albano
Journal:  Int J Mol Sci       Date:  2021-07-02       Impact factor: 5.923

4.  Expression patterns of microRNAs associated with CML phases and their disease related targets.

Authors:  Kateřina Machová Poláková; Tereza Lopotová; Hana Klamová; Pavel Burda; Marek Trněný; Tomáš Stopka; Jana Moravcová
Journal:  Mol Cancer       Date:  2011-04-18       Impact factor: 27.401

Review 5.  The role and mechanisms of action of microRNAs in cancer drug resistance.

Authors:  Wengong Si; Jiaying Shen; Huilin Zheng; Weimin Fan
Journal:  Clin Epigenetics       Date:  2019-02-11       Impact factor: 6.551
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.